Harvard Bioscience (HBIO) FCF Margin (2010 - 2026)
Harvard Bioscience (HBIO) reported FCF Margin of 5.24% for Q1 2026, down 1660.0% year-over-year from 0.34% in Q1 2025, and down 128.3% quarter-over-quarter from 2.3% in Q4 2025.
Harvard Bioscience (HBIO) FCF Margin (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of FCF Margin data on file, last reported at 5.24% in Q1 2026.
- FCF Margin for Q1 2026 came in at 5.24%, down 1660.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.23% (up 167.0% YoY), and the FY2025 annual result was 6.32%, up 760.0% from the prior year.
- FCF Margin eased to 5.24% in Q1 2026 per HBIO's latest filing, from 2.3% in the prior quarter.
- Over five years, FCF Margin peaked at 16.34% in Q3 2023 and troughed at 8.54% in Q1 2022.
- A 5-year average of 3.42% and a median of 4.26% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin tumbled 2418 bps in 2024, then soared 2024 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 8.6% in 2022, then soared by 43 bps to 12.34% in 2023, then sank by 53 bps to 5.8% in 2024, then plunged by 140 bps to 2.3% in 2025, then plunged by 128 bps to 5.24% in 2026.
- Business Quant data shows HBIO's FCF Margin at 5.24% in Q1 2026, 2.3% in Q4 2025, and 4.26% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 29.18% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 11.58% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 4.30% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 36.36% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 7.55% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -13.60% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 8.91% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 11.56% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.81% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -5.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.24% |
| Dec 31, 2025 | -2.30% |
| Sep 30, 2025 | 4.26% |
| Jun 30, 2025 | 13.04% |
| Mar 31, 2025 | 11.36% |
| Dec 31, 2024 | 5.80% |
| Sep 30, 2024 | -7.84% |
| Jun 30, 2024 | -7.20% |
| Mar 31, 2024 | 3.09% |
| Dec 31, 2023 | 12.34% |
| Sep 30, 2023 | 16.34% |
| Jun 30, 2023 | 10.55% |
| Mar 31, 2023 | 5.30% |
| Dec 31, 2022 | 8.60% |
| Sep 30, 2022 | 0.77% |
| Jun 30, 2022 | -2.16% |
| Mar 31, 2022 | -8.54% |
| Dec 31, 2021 | -0.73% |
| Sep 30, 2021 | -3.84% |
| Jun 30, 2021 | 1.92% |